Cullinan Oncology Inc. (CGEM)
NASDAQ: CGEM
· Real-Time Price · USD
7.74
0.16 (2.11%)
At close: Aug 15, 2025, 11:31 AM
2.11% (1D)
| Bid | 7.76 |
| Market Cap | 457.18M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -178.74M |
| EPS (ttm) | -3.16 |
| PE Ratio (ttm) | -2.45 |
| Forward PE | -2.44 |
| Analyst | Buy |
| Ask | 7.77 |
| Volume | 110,564 |
| Avg. Volume (20D) | 343,953 |
| Open | 7.58 |
| Previous Close | 7.58 |
| Day's Range | 7.58 - 7.77 |
| 52-Week Range | 6.85 - 19.89 |
| Beta | -0.07 |
About CGEM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
10 months ago
+8.44%
Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.
